These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10087520)

  • 1. [Olanzapine in the treatment of depressive disorders with psychotic symptoms].
    Adli M; Rossius W; Bauer M
    Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can olanzapine be implicated in causing serotonin syndrome?
    Haslett CD; Kumar S
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):533-5. PubMed ID: 12193243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine response in psychotic depression.
    Rothschild AJ; Bates KS; Boehringer KL; Syed A
    J Clin Psychiatry; 1999 Feb; 60(2):116-8. PubMed ID: 10084638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 6. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD; Bottonari KA; Polania LM; Mischoulon D; Dording CM; Irvin R; Fava M
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
    Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
    J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy].
    Schmitt A; Braus DF
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine: another psychotropic?
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study.
    Marangell LB; Johnson CR; Kertz B; Zboyan HA; Martinez JM
    J Clin Psychiatry; 2002 May; 63(5):391-5. PubMed ID: 12019662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression.
    König F; von Hippel C; Petersdorff T; Neuhöffer-Weiss M; Wolfersdorf M; Kaschka WP
    Neuropsychobiology; 2001; 43(3):170-4. PubMed ID: 11287796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of acute response with olanzapine in psychotic mood disorders.
    Zarate CA; Narendran R; Tohen M; Greaney JJ; Berman A; Pike S; Madrid A
    J Clin Psychiatry; 1998 Jan; 59(1):24-8. PubMed ID: 9491062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperglycemia and ketoacidosis associated with olanzapine].
    Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
    Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.
    Weintraub E; Robinson C
    Ann Clin Psychiatry; 2000 Dec; 12(4):247-9. PubMed ID: 11140927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN; Wasylink S; Epperson CN; McDougle CJ
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract]   [Full Text] [Related]  

  • 19. Addition of olanzapine for treatment-resistant depression.
    Pitchot W; Ansseau M
    Am J Psychiatry; 2001 Oct; 158(10):1737-8. PubMed ID: 11579017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improvement of tardive dyskinesia after treatment with olanzapine].
    Truöl S; Von Hippel C; Raape J; König F
    Psychiatr Prax; 2002 Sep; 29(6):315-7. PubMed ID: 12224042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.